000 | 01535 a2200409 4500 | ||
---|---|---|---|
005 | 20250516171433.0 | ||
264 | 0 | _c20140825 | |
008 | 201408s 0 0 eng d | ||
022 | _a2164-554X | ||
024 | 7 |
_a10.4161/hv.26498 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMuthumani, Kar | |
245 | 0 | 0 |
_aOptimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab. _h[electronic resource] |
260 |
_bHuman vaccines & immunotherapeutics _cOct 2013 |
||
300 |
_a2253-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xblood |
650 | 0 | 4 |
_aBiological Therapy _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Antibodies _xblood |
650 | 0 | 4 |
_aHIV Infections _xtherapy |
650 | 0 | 4 |
_aHIV-1 _ximmunology |
650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xblood |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aPlasmids _xadministration & dosage |
650 | 0 | 4 |
_aRecombinant Proteins _xblood |
650 | 0 | 4 |
_aenv Gene Products, Human Immunodeficiency Virus _ximmunology |
700 | 1 | _aFlingai, Seleeke | |
700 | 1 | _aWise, Megan | |
700 | 1 | _aTingey, Colleen | |
700 | 1 | _aUgen, Kenneth E | |
700 | 1 | _aWeiner, David B | |
773 | 0 |
_tHuman vaccines & immunotherapeutics _gvol. 9 _gno. 10 _gp. 2253-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4161/hv.26498 _zAvailable from publisher's website |
999 |
_c23097094 _d23097094 |